KOR

e-Article

Imatinib compared with second‐generation tyrosine kinase‐inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase.
Document Type
Article
Source
American Journal of Hematology; Jul2023, Vol. 98 Issue 7, pE183-E186, 4p
Subject
Language
ISSN
03618609